Fullerton Fund Management CO Ltd. Regeneron Pharmaceuticals, Inc. Transaction History
Fullerton Fund Management CO Ltd.
- $2.05 Billion
- Q2 2024
A detailed history of Fullerton Fund Management CO Ltd. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Fullerton Fund Management CO Ltd. holds 509 shares of REGN stock, worth $472,616. This represents 0.03% of its overall portfolio holdings.
Number of Shares
509
Previous 509
-0.0%
Holding current value
$472,616
Previous $489,000
9.2%
% of portfolio
0.03%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding REGN
# of Institutions
1,482Shares Held
85.5MCall Options Held
908KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA8.99MShares$8.35 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$7.84 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY8.28MShares$7.69 Billion0.77% of portfolio
-
State Street Corp Boston, MA4.84MShares$4.5 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.64MShares$4.31 Billion0.82% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $99.5B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...